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SUPLEMENTARY FIGURES AND SCHEMES 
 
Figure S1. IR spectra of gaseous decomposition products obtained during TG experiments with 
1(A) and 2 (B). 
 
Figure S2. The 3D presentation of thermal decompositions versus time together with IR spectra 
of their gaseous products: (a) 1; (b) 2. 
 
Figure S3. Overlapped experimental (blue) and calculated (red) powder XRD diffractograms of 
1 (A) and 2 (B). 
 
Figure S4. Comparison between experimental powder XRD patterns of 1 (left) and 2 (right) with 
simulated patterns of their analogues with different position of M‒S bond with respect to the 
TM-CN ring chair conformation. 
 
Figure S5. Optical microscope images of Pt- (left) and Pd-complex (right) showing as-obtained 
single crystals. 
Figure S6. SEM images of Pt- (left) and Pd-complex (right) after reduction to powder for XRD 
measurements. 
Figure S7.  1H NMR spectra of TM-CN in DMSO-d6 (A) and CD3NO2 (B). 
 
Figure S8.  13C NMR spectra of TM-CN in DMSO-d6 (A) and CD3NO2 (B). 
 
Figure S9.  1H (A) and 13C NMR (B) spectra of 1 in DMSO-d6.  
 
Figure S10.  COSY spectrum of 1 in DMSO-d6.  
 
Figure S11.  NOESY spectrum of 1 in DMSO-d6. 
 
Figure S12.  1H–13C HSQC spectrum of 1 in DMSO-d6. 
 
Figure S13.  1H (A) and 13C NMR (B) spectra of 1 in CD3NO2.  
 
Figure S14.  1H (A) and 13C NMR (B) spectra of 2 in DMSO-d6.  
 
Figure S15.  1H (A) and 13C NMR (B) spectra of 2 in CD3NO2.  
 






Table S1. Experimental vibrational frequencies (cm-1) and signals description of complexes 
studied. 
 
Table S2. Crystal data and structure refinement for 1 and 2. 
 
Table S3. Selected bond lengths (Å) and angles (°) for complexes 1 and 2. 
 
Table S4. Results of energy calculations for C-H/Cl-M, C-H/S-M, C-H/M and C-H/NC 
interactions (M= Pd(II) and Pt(II)) at wb97xd/6-31+g** +lanl2dz level of theory. Energies are 
expressed in kcal/mol. 
 
Table S5. C-H/M interactions obtained from the periodic calculations of axial and equatorially 
coordinated Pd and Pt. 
 
Table S6. 1H NMR spectral data (399.74 MHz) in DMSO-d6 and CD3NO2 at 298 K for TM-CN 
and complexes 1 and 2. 
 
Table S7. 13C NMR spectral data (100.53 MHz) in DMSO-d6 and CD3NO2 at 298 K for TM-CN 
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2997 w (91) 
CH2 sym 
CH2 asym 
2995 ms (90) CH2 sym 
CH2 asym 2980 w (89) 2925 vw (93) 
2916 vw (91) 2263 ms (88) 
ν C≡N 
2867 vw (91) 2214 s (80) 
2208 vs (59) ν C≡N 1649 ms (89) 
ν C-S 
1652 w (93) 
ν C-S 
1597 ms (89) 
1598 w (92) 1546 ms (91) 
1454 s (82) 1401 s (81) 
1420 s (79) 1277 s (84) 
ν C-C  
CH2 wag  
CH2 twist 




1197 mw (88) 
1364 s (78) 1166 mw (86) 
1283 s (82) 1113 mw (87) 
 1227 ms (87) 1029 s (85) b C≡N 
1197 ms (87) 946 vs (67) 
CH2 rock 
1176 ms (83) 832 w (91) 
1147 ms (82) 734 mw (89) 
1120 s (78) 648 mw (89) 
1027 s (79) b C≡N 573 mw (86) 
980 ms (83) CH2 rock 543 mw (85) b NCN 
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949 vs (56) 504 s (79) ν Pd-S 
726 ms (88) 374 vw (90) 
ν Pd-Cl 
580 s (84) 364 w (84) 
540 ms (88) b NCN 355 vs (56) 
505 vs (74) ν Pt-S 333 s (78) 
354 vs (53) 
ν Pt-Cl 
319 vs (28) 
347 vs (25)    
339 vs (10) 
321 vs (22) 
 
Abbreviations used: ν = streching; b = bending; wag = wagging; twist = twisting; rock = rocking; 
sym = symmetric stretch; asym = asymmetric stretch; w = weak; m = medium; s = strong; ms = 















Table S2. Crystal data and structure refinement for 1 and 2. 
 
Compound 1 2 
Molecular formula C10H16Cl2N4PtS2 C10H16Cl2N4PdS2 
Formula weight 522.38 433.69 
Temperature (K) 294(2) 294(2) 
Wavelength (Å) 0.71073 0.71073 
Crystal system Monoclinic Monoclinic 
Space group I 2/a P 21/c 
a (Å) 9.9954(3) 11.4399(4) 
b (Å) 11.0764(3) 7.0711(2) 
c (Å) 14.8663(4) 9.5192(4) 
β (°) 107.508(3) 96.179(4) 
Volume (Å3) 1569.64(7) 765.56(5) 
Z 4 2 
ρcalc (Mg/m
3) 2.211 1.881 
μ (mm–1) 9.537 1.82 
F(000) 992 432 
Crystal size (mm) 0.61 × 0.14 × 0.11 0.51 × 0.49 × 0.14 
θ Range for data collection (°) 2.33 – 28.93 3.39 – 29.06 
Reflections collected 7449 25252 
Independent reflections 1903 [R(int) = 0.046] 3440 [R(int) = 0.070] 
Absorption correction Gaussian Analytical 
Refinement method full-matrix least-squares on F2 
Data/restraints/parameters 1903/0/89 3440/0/90 
Goodness-of-fit on F2 1.27 1.25 
Final R indexes [I > 2σ(I)] R1 = 0.0327, wR2 = 0.0802 R1 = 0.0505, wR2 = 0.1176 
Final R indexes [all data] R1 = 0.0387, wR2 = 0.0835 R1 = 0.0551, wR2 = 0.1211 
Largest diff. peak and hole,  
e Å–3 
1.06 and –2.18 1.30 and –1.66 
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 1 2 
M1a–Cl1 2.3059(11) 2.2981(9) 
M1–S1 2.3135(10) 2.3121(9) 
S1–C1 1.816(5) 1.823(4) 
S1–C3 1.810(5) 1.808(4) 
N1–C2 1.463(6) 1.471(6) 
N1–C5 1.315(6) 1.317(6) 
N1–C4 1.454(6) 1.452(6) 
Cl1–M1–S1i 86.43(4) 95.34(3) 
Cl1–M1–Cl1i 180 180 
S1–M1–Cl1 93.57(4) 84.66(3) 
S1–M1–S1i 180 180 
C5–N1–C4 118.1(4) 121.7(4) 
C5–N1–C2 118.1(4) 119.2(4) 
C4–N1–C2 117.6(4) 118.2(3) 
M1a‒S1‒C1‒C2 60.89 172.48 
M1a‒S1‒C3‒C4 59.80 167.98 
a M = Pt in 1; M = Pd in 2.  
i = 1 – x, 1 – y, 1 – z in 1;  















Table S4. Results of energy calculations for C‒H/Cl‒M, C‒H/S‒M, C‒H/M and C‒H/NC 



















2.50 0.09 0.06 0.85 0.56 ‒2.21 ‒1.82 ‒0.39 ‒0.39 
2.70 ‒0.42 ‒0.44 ‒0.20 ‒0.44 ‒2.78 ‒2.70 ‒0.56 ‒0.56 
2.80 ‒0.54 ‒0.55 ‒0.47 ‒0.69 ‒2.84 ‒2.88 ‒0.57 ‒0.57 
2.90 ‒0.59 ‒0.60 ‒0.63 ‒0.83 ‒2.80 ‒2.95 ‒0.56 ‒0.56 
3.00 ‒0.60 ‒0.62 ‒0.72 ‒0.90 ‒2.71 ‒2.93 ‒0.54 ‒0.54 
3.20 ‒0.58 ‒0.59 ‒0.75 ‒0.90 ‒2.43 ‒2.72 ‒0.48 ‒0.48 







Table S5. C‒H/M interactions obtained from the periodic calculations of axial and equatorially 
coordinated Pd and Pt. 
 
 
Complex Number of C‒H/M 
interactions 
C‒H/M distances (Å) 
2 4 3.785, 4.050, 4.481, 4.933 
1 5 3.326, 3.955, 4.798, 4.863, 5.892 
2-ax 5 3.719, 4.681, 4.683, 5.164, 5.643 

















Table S6. 1H NMR spectral data (399.74 MHz) in DMSO-d6 and CD3NO2 at 298 K for TM-CN 
and complexes 1 and 2. 
 DMSO-d6 CD3NO2 
TM-CN 
δ 3.40 – 3.36 (m, 4H, CβH2 = 
Cβ’H2), 2.64 (dd, J = 6.2, 3.9 Hz, 
4H, CαH2 = C
α’H2). 
δ 3.47 – 3.39 (m, 4H, CβH2 = 
Cβ’H2), 2.70 (dd, J = 6.2, 3.9 Hz, 
4H, CαH2 = C
α’H2). 
1 
1-ax (minor): δ 3.75 (br. d, J = 12.1 
Hz, 2H, CβHD = C
β’HD’), 3.50 (br. s, 
2H, CβHC = C
β’HC’), 3.46 (br. s, 2H, 
CαHB = C
α’HB’), 3.06 (br. d, J = 
10.9 Hz, 1H, CαHA = C
α’HA’). 
1-ax (major): δ 3.93 (m, CβHD = 
Cβ’HD’), 3.56 (d, J = 14.9 Hz, C
βHC 
= Cβ’HC’), 3.50 (d, J = 12.1 Hz, 
CαHB = C
α’HB’), 3.01 (m, C
αHA = 
Cα’HA’). 
TM-CN (major): δ 3.38 (m, 4H, 
CβH2 = C
β’H2), 2.63 (m, 4H, C
αH2 
= Cα’H2). 
1-eq (minor): δ 3.77 (d, CβHC = 
Cβ’HC’), 3.67 (m, C
αHA = C
α’HA’), 
3.56 (ovlp., CβHD = C
β’HD’), 3.07 
(ovlp, CαHB = C
α’HB’). 
2 
δ 3.52 (br. s, 4H, CαH2 = C
α’H2), 
2.80 (br. s, 4H, CαH2 = C
α’H2) 
δ 3.76 (br. s, 4H, CαH2 = C
α’H2), 





Table S7. 13C NMR spectral data (100.53 MHz) in DMSO-d6 and CD3NO2 at 298 K for TM-CN 
and complexes 1 and 2. 
 DMSO-d6 CD3NO2 
TM-CN 
δ 117.91 (Cγ), 50.68 (Cβ = Cβ’), 
25.84 (Cα = Cα’). 
δ 117.47 (Cγ),  50.67 (Cβ = Cβ’), 
25.56 (Cα = Cα’). 
1 
1-ax: δ 116.98 (Cγ), 48.80 (Cβ = 
Cβ’), 31.79 (Cα = Cα’).  
1-ax (major): δ 116.65 (Cγ), 48.39 
(Cβ = Cβ’), 28.93 (Cα = Cα’). 
TM-CN: δ 117.96 (Cγ), 50.68 (Cβ = 
Cβ’), 25.70 (Cα = Cα’). 
1-eq (minor): δ 116.61 (Cγ), 48.83 
(Cβ = Cβ’), 30.89 (Cα = Cα’). 
2 
δ 117.48 (Cγ), 49.99 (Cβ = Cβ’), 
27.46 (Cα = Cα’). 
δ 116.65 (Cγ), 49.29 (Cβ = Cβ’), 
29.76 (Cα = Cα’). 
 
  
